Well you would have thought that with a world beating product, buyers at the door results just about to be released, the company would have attracted some high caliber candidates for the Board position.
New blood would have enable a new network of contacts and expose to help promote the company and if the individual had a connection wit the healthcare/pharma sector it would have brought new value to the sp.
in my opinion this is a lost opportunity!
what do others think??
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EMS (ASX) Chart |
Day chart unavailable